Mycoplasma Genitalium Is an Emerging Cause of Genital Tract Infections

Multiple Choice

Mycoplasma genitalium is an emerging cause of genital tract infections in men and women worldwide. The organism was discovered and identified only in the early 1980s. Rising incidence and increasing resistance to antimicrobial medications are problematic. You are asked by your nursing professor to prepare a short presentation on this emerging disease. The questions that follow are those that you anticipate that being asked by your classmates.
-Suspected M. genitalium infections are treated with antibiotics such as macrolides. Why are these infections "suspected" and why are they treated with macrolide antibiotics?

A) The signs and symptoms of M. genitalium infections are unique and diagnosis can thus be based on them AND mycoplasmas are intrinsically resistant to peptidoglycan synthesis inhibitors so are treated with antibiotics that target other cellular activities such as protein synthesis.
B) Signs and symptoms of M. genitalium infections resemble those of other STIs, confusing the diagnosis of this disease AND mycoplasmas are intrinsically resistant to protein synthesis inhibitors so are treated with antibiotics that target other cellular activities such as DNA replication.
C) The signs and symptoms of M. genitalium infections are unique and diagnosis can thus be based on them AND mycoplasmas are viruses, so there are very limited choices in the available medications used for treating these infections.
D) A person with M. genitalium never has signs and symptoms, so infection is suspected if they have other STIs AND mycoplasmas are intrinsically resistant to peptidoglycan synthesis inhibitors so are treated with antibiotics that target other cellular activities such as protein synthesis. 
E) There are no approved diagnostic tools for M. genitalium infections, so it is not possible to easily confirm the diagnosis AND mycoplasmas are intrinsically resistant to peptidoglycan synthesis inhibitors so are treated with antibiotics that target other cellular activities such as protein synthesis.